The role of colostrum proline-rich polypeptides in human immunological and neurological health

Lecture Notes in Electrical Engineering

Volumn 12 LNEE, Issue , 2008, Pages 233-243

  Keech, Andrew ^b   Buhmeyer, John I ^b   Kolt, Richard ^a  

^a Rejuvalight LED Technology   (United States)

^b NONE

Author keywords

AIDs; Colostrum

Indexed keywords

AIDS; COLOSTRUM; ME-XICO; PHOTOBIOMODULATION;

ELECTRICAL ENGINEERING; MATHEMATICAL TECHNIQUES;

TISSUE REGENERATION;

EID: 84885012224     PISSN: 18761100     EISSN: 18761119     Source Type: Book Series    
DOI: 10.1007/978-0-387-71809-5_22     Document Type: Conference Paper

References (117)

1. Steven J. Bock, PRPS and its clinical applications. International Journal of Integrative Medicine.
2. Solomons, NW, Modulation of the immune system and the response against pathogens with bovine colostrum concentrates. European Journal of Clinical Nutrition 56(Suppl. 3):S24-S28 (2002).
3. owiadczalne j 59:309-323 (2005).
4. Chaplin, DD. Overview of the human immune response. Journal of Allergy and Clinical Immunology 117(Suppl. 2):S430-S435 (2006).
5. Mosmann, TR, Cherwinski, H, Bond, MW, et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. Journal of Immunology 136:2348-2357 (1986).
6. Mosmann, TR, Coffman, RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annual Reviews of Immunology 7:145-173 (1989).
7. Mosmann, TR, Sad, S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunology Today 17:138-146 (1996).
8. Abbas, AK, Murphy, KM, Sher, A. Functional diversity of helper T lymphocytes. Nature 383:787-793 (1996).
9. McGuirk, P, Mills, KH. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends in Immunology 23:450-455 (2002).
10. Wieczorek, Z, Zimecki, M, Janusz, M, Staroscik, K, Lisowski, J. Proline-rich polypeptide from ovine colostrum: its effect on skin permeability and on the immune response. Immunology 36(4):875-881 (1979).
11. Staroscik, K, Janusz, M, Zimecki, M, Wieczorek, Z, Lisowski, J. Immunologically active nonapeptide fragment of a proline-rich polypeptide from ovine colostrum: amino acid sequence and immunoregulatory properties. Molecular Immunology 20(12):1277-1282 (1983).
12. Janusz, M, Staroscik, K, Zimecki, M, Wieczorek, Z, Lisowski, J. A proline-rich polypeptide (PRP) with immunoregulatory properties isolated from ovine colostrum. Murine thymocytes have on their surface a receptor specific for PRP. Archivum immunologiae et therapiae experimentalis (Warszava) 34(4):427-436 (1986).
13. Janusz, M, Lisowski, J. Proline-rich polypeptide (PRP)-an immunomodulatory peptide from ovine colostrum. Archivum immunologiae et therapiae experimentalis (Warszava) 41(5-6):275-279 (1993).
14. Zimecki, M, Staroscik, K, Janusz, M, Lisowski, J, Wieczorek, Z. The inhibitory activity of a proline-rich polypeptide (PRP) on the immune response to polyvinylpyrrolidone (PVP). Archivum immunologiae at therapiae experimentalis (Warszava) 31(6):895-903 (1983).
15. Wieczorek, Z, Zimecki, M, Spiegel, K, Lisowski, J, Janusz, M. Differentiation of T cells into helper cells from immature precursors: identification of a target cell for a proline-rich polypeptide (PRP). Archivum immunologiae at therapiae experimentalis (Warszava) 37(3-4):313-322 (1989).
16. Zimecki, M, Pierce, CW, Janusz, M, Wieczorek, Z, Lisowski, J. Proliferative response of T lymphocytes to a proline-rich polypeptide (PRP): PRP mimics mitogenic activity of II-1. Archivum immunologiae et therapiae experimentalis (Warszava) 35(3):339-349 (1987).
17. Zimecki, M, Janusz, M, Staroscik, K, Wieczorek, Z, Lisowski, J. Immunological activity of a proline-rich polypeptide from ovine colostrum. Archivum immunologiae et therapiae experimentalis (Warszava) 26(1-6):23-29 (1978).
18. Zimecki, M, Lisowski, J, Hraba, T, Wieczorek, Z, Janusz, M, Staroscik, K. The effect of a proline-rich polypeptide (PRP) on the humoral immune response. II. PRP induces differentiation of helper cells from glass-nonadherent thymocytes (NAT) and suppressor cells from glass-adherent thymocytes (GAT). Archivum immunologiae at therapiae experimentalis (Warszava) 32(2):197-201 (1984).
19. Lisowski, J, Wieczorek, Z, Janusz, M, Zimecki, M. Proline-rich polypeptide (PRP) from ovine colostrum. Bi-directional modulation of binding of peanut agglutinin, resistance to hydrocortisone, and helper activity in murine thymocytes. Archivum immunologiae et therapiae experimentalis (Warszava) 36(4):381-393 (1988).
20. Julius, MH, Janusz, M, Lisowski, J. A colostral protein that induces the growth and differentiation of resting B lymphocytes. Journal of Immunology 140(5):1366-1371 (1988).
21. Kruzel, ML, Janusz, M, Lisowski, J, Fischleigh, RV, Georgiades, JA. Towards an understanding of biological role of colostrinin peptides. Journal of Molecular Neuroscience 17 (3):379-389 (2001).
22. Boldogh, I, Liebenthal, D, Hughes, TK, Juelich, TL, Georgiades, JA, Kruzel, ML, Stanton, GJ. Modulation of 4HNE-mediated signaling by proline-rich peptides from ovine colostrum. Journal of Molecular Neuroscience 20(2):125-134 (2003).
23. Kubis, A, Marcinkowska, E, Janusz, M, Lisowski, J. Studies on the mechanism of action of a prolinerich polypeptide complex (PRP): effect on the stage of cell differentiation. Peptides 26(11):2188-2192 (2005).
24. Inglot, AD, Janusz, M, Lisowski, J. Colostrinine: a proline-rich polypeptide from ovine colostrum is a modest cytokine inducer in human leukocytes. Archivum immunologiae et therapiae experimentalis (Warszava) 44(4):215-224 (1996).
25. Blach-Olszewska, Z, Janusz, M. Stimulatory effect of ovine colostrinine (a proline-rich polypeptide) on interferons and tumor necrosis factor production by murine resident peritoneal cells. Archivum immunologiae et therapiae experimentalis (Warszava) 45(1):43-47 (1997).
26. Domaraczenko, B, Janusz, M, Orzechowska, B, Jarosz, W, Blach-Olszewska, Z. Effect of proline rich polypeptide from ovine colostrum on virus replication in human placenta and amniotic membrane at term; possible role of endogenous tumor necrosis factor alpha. Placenta 20(8):695-701 (1999).
27. Khan, A. Non-specificity of transfer factor. Annals of Allergy 38(5):320-322 (1977).
28. Keech, A. Unpublished data (2006).
29. Staroscik, K, Janusz, M, Zimecki, M, Wieczorek, Z, Lisowski, J. Immunologically active nonapeptide fragment of a proline-rich polypeptide from ovine colostrum: amino acid sequence and immunoregulatory properties. Molecular Immunology 20(12):1277-1282 (1983).
30. Janusz, M, Wieczorek, Z, Spiegel, K, Kubik, A, Szewczuk, Z, Siemion, I, Lisowski, J. Immunoregulatory properties of synthetic peptides, fragments of a proline-rich polypeptide (PRP) from ovine colostrum. Molecular Immunology 24(10):1029-1031 (1987).
31. Siemion, IZ, Folkers, G, Szewczuk, Z, Jankowski, A, Kubik, A, Voelter, W. Peptides related to the active fragment of "proline rich polypeptide", an immunoregulatory protein of the ovine colostrum. Spectroscopic and computer modeling studies. International Journal of Protein and Peptide Research 36(6):506-514 (1990).
32. Sokal, I, Janusz, M, Miecznikowska, H, Kupryszewski, G, Lisowski, J. Effect of colostrinin, an immunomodulatory proline-rich polypeptide from ovine colostrum, on sialidase and betagalactosidase activities in murine thymocytes. Archivum immunologiae et therapiae experimentalis (Warszava) 46(3):193-198 (1998).
33. Khan, A. Transfer factor in viral diseases. The Lancet 1(8059):328-329 (1978).
34. Orzechowska, B, Blach-Olszewska, Z. Acquisition of susceptibility to vesicular stomatitis virus infection by murine resident peritoneal cells during culturing in vitro. Archivum immunologiae et therapiae experimentalis (Warszava) 44(5-6):325-328 (1996).
35. Orzechowska, B, Janusz, M, Domaraczenko, B, Blach-Olszewska, Z. Antiviral effect of proline-rich p olypeptide in murine resident peritoneal cells. Acta Virologica 42(2):75-78 (1998).
36. Pizza, G, Meduri, R, De Vinci, C, Scorolli, L, Viza, D. Transfer factor prevents relapses in herpes keratitis patients: a pilot study. Biotherapy 8(1):63-68 (1994).
37. Pizza, G, Viza, D, De Vinci, C, Palareti, A, Cuzzocrea, D, Fornarola, V, Baricordi, R. Orally administered HSV-specific transfer factor (TF) prevents genital or labial herpes relapses. Biotherapy 9(1-V):67-72 (1996).
38. Meduri, R, Campos, E, Scorolli, L, De Vinci, C, Pizza, G, Viza, D. Efficacy of transfer factor in treating patients with recurrent ocular herpes infections. Biotherapy 9(1-3):61-66 (1996).
39. "Colostrum contains Retinoic Acid, which helps fight herpes virus. It also contains glycoprotein (kappa casein) that protects against the bacteria that cause stomach ulcers." - Dr. Raloff in Science News.
40. Prasad, U, bin Jalaludin, MA, Rajadurai, P, Pizza, G, De Vinci, C, Viza, D, Levine, PH. Transfer factor with anti-EBV activity as an adjuvant therapy for nasopharyngeal carcinoma: a pilot study. Biotherapy 9(1-3):109-115 (1996).
41. Claes-Henrik, F., Chinenye, S., Elfstrand L., Hagman, C., Ihse, I., ColoPlus, A new product based on bovine colostrum, alleviates HIV-associated diarrhea. Scandinavian Journal of Gastroenterology, 41:682-686 (2006).
42. Raise, E, Guerra, L, Viza, D, Pizza, G, De Vinci, C, Schiattone, ML, Rocaccio, L, Cicognani, M, Gritti, F. Preliminary results in HIV-1-infected patients treated with transfer factor (TF) and zidovudine (ZDV). Biotherapy 9(1-3):49-54 (1996).
43. Heaton, P. Bovine colostrum immunoglobulin concentrate for cryptosporidiosis in AIDS. Archives of Disease in Childhood 70(4):356-357 (1994).
44. Shield, J, Melville, C, Novelli, V, Anderson, G, Scheimberg, I, Gibb, D, Milla, P. Bovine colostrum immunoglobulin concentrate for cryptosporidiosis in AIDS. Archives of Disease in Childhood 69(4):451-453 (1993).
45. Rump, JA, Aarndt, R, Arnold, A, Bendick, C, Dichtelmuller, H, Franke, M, Helm, EB, Jager, H, Kampmann, B, Kolb, P, et al. Treatment of diarrhoea in human immunodeficiency virusinfected patients with immunoglobulins from bovine colostrum. Clinical Investigator 70 (7):588-594 (1992).
46. Plettenberg, A et al. A preparation from bovine colostrum in the treatment of HIV positive patients with chronic diarrhea. Clinical Investigator (Jan. 1993).
47. Richie, J. Update on the management of intestinal cryptosporidiosis in AIDS. Annals of Pharmacotherapy 28:767-778 (1994).
48. Unger, BLP et al. Cessation of cryptosporidium-associated diarrhea in AIDS patients after treatment with hyperimmune bovine colostrum. Gastroenterology 98:486-489 (1990).
49. Ritchie, DJ, Update on the management of intestinal cryptosporidiosis in AIDS. Annals of Pharmacotherapy 28:767-778 (1994).
50. Greenberg PD, Cello JP. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 13(4):348-354 (Dec. 1, 1996).
51. Plettenberg, A et al. A preparation from bovine colostrum in the treatment of HIV-positive patients with chronic diarrhea. Clinical Investigator 71(1):42-45 (1993).
52. Greenberg, PD, Cello, JP. Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS. Journal of Acquired Immunodeficiency Syndromes and Human Retrovirology 13(4):348-354 (1996).
53. "Reducing viral levels in the body and stimulating natural immune capabilities holds the most promise in helping our immune systems contain the HIV virus," according to Dr. Nowa and Dr. McMichael in Scientific American.
54. Shortridge, KF, Lawton, JW, Choi, EK. Protective potential of colostrum and early milk against prospective influenza viruses. Journal of Tropical Pediatrics 36(2):94-95 (1990).
55. Qiu, J, Hendrixson, DR, Baker, EN, Murphy, TF, St. Game, JW, III, Plaut, AG. Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. Proceedings of the National Academy of Science (USA) 95(21):12641-12646 (1998).
56. Hilpert, H, Brussow, H, Mietens, C, Sidoti, J, Lerner, L, Werchau, H. Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. Journal of Infectious Disease 156(1):58-166 (1987).
57. Brussow, H, Hilpert, H, Walther, I, Sidoti, J, Mietens, C, Bachmann, P. Bovine milk immunoglobulins for passive immunity to infantile rotavirus gastroenteritis. Journal of Clinical Microbiology 25(6):982-986 (1987).
58. Ebina, T, Sato, A, Umezu, K, Ishida, N, Ohyama, S, Ohizumi, A, Aikawa, K, Katagiri, S, Katsushima, N, Imai, A. Prevention of rotavirus infection by cow colostrum antibody against human rotaviruses. Lancet 2(8357):1029-1030 (1983).
59. Ebina, T, Sato, A, Umezu, K, Ishida, N, Ohyama, S, Oizumi, A, Aikawa, K, Katagiri, S, Katsushima, N, Imai, A. Prevention of rotavirus infection by oral administration of cow colostrum containing anti-human rotavirus antibody. Medical Microbiology and Immunity (Berlin) 174(4):177-185 (1985).
60. Ebina, T, Ohta, M, Kanamaru, Y, Yamamoto-Osumi, Y, Baba, K. Passive immunizations of suckling mice and infants with bovine colostrum containing antibodies to human rotavirus. Journal of Medical Virology 38(2):117-123 (1992).
61. Ebina, T. Prophylaxis of rotavirus gastroenteritis using immunoglobulin. Archives of Virology Supplement 12:217-223 (1996).
62. Sarker, SA, Casswall, TH, Mahalanabis, D, Alam, NH, Albert, MJ, Brussow, H, Fuchs, GJ, Hammerstrom, L. Successful treatment of rotavirus diarrhea in children with immunoglobulin from, immunized bovine colostrum. Pediatric Infectious Disease Journa 17(12):1149-1152 (1998).
63. Davidson, GPE, Nunan, H, Moore, AG, Whyte, PBD, Franklin, K, McCloud, PL, Moore, DJ. Passive Immunization of children with bovine colostrum containing antibodies to human rotavirus. Lancet 2:709-712 (1989).
64. Mitra, AK, Mahalanabis, D, Ashraf, H, Unicomb, L, Eeckels, R, Tzipori, S. Acta Paediatrica 84(9):996-1001 (Sep. 1995).
65. Yolken, RH et al. Antibody to human rotavirus in cow's milk. New England Journal of Medicine 312(10):605-610 (1985).
66. Sabin, AB. Anti-poliomyelitic substance in milk from human beings and certain cows. Journal of Diseases of Children 80:866-870 (1950).
67. Palmer, EL et al. Antiviral activity of colostrum and serum immunoglobulins A and G. Journal of Medical Virology 5:123-129 (1980).
68. Petschow, BW, Talbott, RD. Reduction in virus-neutralizing activity of a bovine colostrum immunoglobulin concentrate by gastric acid and digestive enzymes. Journal of Pediatric Gastroenterology and Nutrition 19(2):228-235 (1994).
69. Theodore, C et al. "Immunologic Aspects of Colostrum and Milk: Development of Antibody Response to Respiratory Syncytial Virus and Bovine Serum Albumin in the Human and Rabbit Mammary Gland" Recent Advances in Mucosal Immunity (1982) (Raven Press), New York.
70. Immunoglobulin components and anti-viral activities in bovine colostrum. Kansenshogaku Zassh 64(3):274-279 (Mar. 1990).
71. van Hooijdonk AC, Kussendrager KD, Steijns JM., In vivo antimicrobial and antiviral activity of components in bovine milk and colostrum involved in non-specific defence. British Journal of Nutrition 84(Suppl. 1):S127-134 (Nov. 2000).
72. Ushijima, H, Dairaku, M, Honnma, H, Mukoyama, A, Kitamura, T. Kansenshogaku Zasshi 64(3):274-279 (Mar. 1990).
73. Ushijima, H, Dairaku, M, Honnma, H, Mukoyama, A, Kitamura, T. (1990) Immunoglobulin components and anti-viral activities in bovine colostrum. 64:274-279.
74. Orzechowska, B et al. Antiviral effect of proline-rich polypeptide in murine resident peritoneal cells. Acta Virologica 42(2):75-78 (1998).
75. Ferrer-Argote, VE, Romero-Cabello, R, Hernandez-Mendoza, L, Arista-Viveros, A, Rojo- Medina, J, Balseca-Olivera, F, Fierro, M, Gonzalez-Constandse, R. Successful treatment of severe complicated measles with non-specific transfer factor. In Vivo 8(4):555-557 (1994).
76. Tzipori, S, Roberton, D, Chapman, C. Remission of diarrhoea due to cryptosporidiosis in an immunodeficient child treated with hyperimmune bovine colostrum. British Medical Journal (Clinical Research Edition) 293(6557):1276-1277 (1986).
77. Orzechowska, B, Janusz, M, Domaraczenko, B, Beach-Olszewska, B, Antiviral effect of proline-rich polypeptide in murine resident peritoneal cells. Acta Virologica 42:75-78 (1998).
78. Ferrer-Argote, VE, Romero-Cabello, R, Hernandez-Mendoza, L, Arista-Viveros, A, Rojo-Medina, J, Balseca-Olivera, F, Fierro, M, Gonzalez-Constandse, R. Successful treatment of severe complicated measles with non-specific transfer factor. In Vivo 8(4):555-557 (1994).
79. Chan, MC, Cheung, CY, Chui, WH, Tsao, SW, Nicholls, JM, Chan, YO, Chan, RW, Long, HT, Poon, LL, Guan, Y, Peiris, JS. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in grimary human alveolar and bronchial epithelial cells. Respiratory Research 6:135 (2005).
80. Lawrence, HS. Transfer factor and autoimmune disease. Annals of the New York Academy of Science 124(1):56-60 (1965).
81. Hraba, T, Wieczorek, Z, Janusz, M, Lisowski, J, Zimecki, M. Effect of proline-rich polypeptide on experimental autoimmune response to erythrocytes. Archivum immunologiae et therapiae experimentalis (Warszava) 34(4):437-443 (1986).
82. Savilahti, E, Tainio, VM, Salmenpera, L, Arjomaa, P, Kallio, M, Perheentupa, J, Siimes, MA. Low colostral IgA associated with cow's milk allergy. Acta Paediatrica Scandinavica 80(12):1207-1213 (1991).
83. Delespesse, G. Polypeptide factors from colostrum. US Patent #5,371,073 (1994).
84. Collins, AM et al. Bovine milk, including pasteurized milk, contains antibodies directed against allergens of clinical importance to man. International Archives of Allergy and Applied Immunology 96:362-367 (1991).
85. Institute of Chemistry and Biochemistry, Helibrunner Str. 34, 5020 Salzburg, Austria. Univ.-Prof. Dr. Albert Duschl, http://tapir.sbg.ac.at/ allergy.htm
86. Grohn, P, Anttila, R, Krohn, K. The effect of non-specifically acting transfer factor component on cellular immunity in juvenile rheumatoid arthritis. Scandinavian Journal of Rheumatology 5(3):151-157 (1976).
87. "The Clinical Use of Bovine Colostrum", Alejandro Nitsch, MD, Fabiola P. Nitsch, MD.
88. De Keyser, F, et al. Gut inflammation and spondyloarthropathies. Current Rheumatology Reports 4(6):525-532 (2002).
89. Op. cit., Fallanc, L, p. 192. Feldmann, M, Brennan, F, Maini, R. Role of cytokines in rheumatoid arthritis. Annals of Review in Immunology 14:397-440 (1996).
90. Feldmann, M, Brennan, F, Maini, R. Role of cytokines in rheumatoid arthritis. Annual Review of Immunology 14:397-440 (1996).
91. Khan, A, Sellars, W, Grater, W, Graham, MF, Pflanzer, J, Antonetti, A, Bailey, J, Hill, NO. The usefulness of transfer factor in asthma associated with frequent infections. Annals of Allergy 40(4):229-232 (1978).
92. Runa Ali, F, Barry Kay, A, Larcha, M. The potential of peptide immunotherapy in allergy and asthma. Current Allergy and Asthma Reports (2001).
93. Basten, A, McLeod, JG, Pollard, JD, Walsh, JC, Stewart, GJ, Garrick,. R, Frith, JA, Van Der Brink, CM. Transfer factor in treatment of multiple sclerosis. The Lancet 2(8201):931-934 (t980).
94. Ebina, T, et al. "Treatment of multiple sclerosis with anti-measles cow colostrum." Med Microbiol Immunol (Berl) 173(2):87-93 (1984).
95. De Vinci, C, Levine, PH, Pizza, G, Fudenberg, HH, Orens, P, Pearson, G, Viza, D. Lessons from a pilot study of transfer factor in chronic fatigue syndrome. Biotherapy 9(1-3):87-90 (1996).
96. Pizza, G, et al. A preliminary report on the use of transfer factor for treating stage D3 hormone-unresponsive metastatic prostate cancer. Biotherapy 9(1-3):123-132 (1996).
97. Transfer factor (PRPs) increased the survival rate of stage D3 prostate cancer patients.
98. See, D, et al. Increased tumor necrosis factor alpha (TNF-alpha) and natural killer cell (NK) function using an integrative approach in late stage cancers. Immunological Investigations 31(2):137-153 (2002).
99. Leszek, J, Inglot, AD, Janusz, M, Lisowski, J, Krukowska, K, Georgiades, JA. Colostrinin: a prolinerich polypeptide (PRP) complex isolated from ovine colostrum for treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Archivum immunologiae et therapiae experimentalis (Warszava) 47(6):377-385 (1999).
100. Leszek, J, Inglot, AD, Janusz, M, Byczkiewicz, F, Kiejna, A, Georgiades, J, Lisowski, J. Colostrinin proline-rich polypeptide complex from ovine colostrum-a long-term study of its efficacy in Alzheimer's disease. Medical Science Monitor 8(10):193-196 (2002).
101. Bilikiewicz, A, Gaus, W. Colostrinin (a naturally occurring, proline-rich, polypeptide mixture) in the treatment of Alzheimer's disease. Journal of Alzheimer's Disease 6(1):17-26 (2004).
102. Popik, P, Bobula, B, Janusz, M, Lisowski, J, Vetulani, J. Colostrinin, a polypeptide isolated from early milk, facilitates learning and memory in rats. Pharmacology and Biochemistry of Behavior 64(1):183-189 (1999).
103. Popik, P, Galoch, Z, Janusz, M, Lisowski, J, Vetulani, J. Cognitive effects of Colostral-Val nonapeptide in aged rats. Behavioral Brain Research 118(2):201-208 (2001).
104. Stewart, MG, Banks, D. Enhancement of long-term memory retention by Colostrinin in one-day-old chicks trained on a weak passive avoidance learning paradigm. Neurobiology of Learning and Memory prepublication (2006).
105. Mikulska, JE, Lisowski, J. A proline-rich polypeptide complex (PRP) from ovine colostrum. Studies on the effect of PRP on nitric oxide (NO) production induced by LPS in THP-1 cells. Immunopharmacology and Immunotoxicology 25(4):645-654 (2003).
106. Zablocka, A, Janusz, M, Macala, J, Lisowski, J. A proline-rich polypeptide complex and its nonapeptide fragment inhibit nitric oxide production induced in mice. Regulatory Peptides 125(1-3):35-39 (2005).
107. Schuster, D, Rajendran, A, Hui, SW, Nicotera, T, Srikrishnan, T, Kruzel, ML. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of betaamyloid. Neuropeptides 39(4):419-426 (2005).
108. Stoff, JA, The use of dialyzable bovine colostrum extract in conjunction with a holistic treatment model for natural killer cell stimulation in chronic illness. Obtained by Mato/ Botanical International (1-800-363-1890).
109. Stoff, J, et al. An Examination of Immune Response Modulation in Humans by AUE1Q0 Utilizing A Double Blind Study. Townsend Letter April, 2002.
110. Godden, SM, et al. Effect of on-farm commercial batch pasteurization of colostrum on colostrum and serum immunoglobulin concentrations in dairy calves. Journal of Dairy Science 86(4):1503-1523 (2003).
111. Meylan, M, et al. Survival of Mycobacterium paratuberculosis and preservation of immunoglobulin G in bovine colostrum under experimental conditions simulating pasteurization. American Journal of Veterinary Research 57(11):1580-1585 (1996).
112. Li-Chan, E, et al. Stability of bovine immunoglobulins to thermal treatment and processing. Food Research International 28(1):9-16 (1995).
113. Dominguez, E, et al. Effect of heat treatment on the antigen-binding activity of antiperoxidase immunoglobulins in bovine colostrum. Journal of Dairy Science 80(12):3182-3187 (1997).
114. Collier, RJ, et al. Factors affecting insulin-like growth factor-1 concentration in bovine milk. Journal of Dairy Science 74(9):2905-2911 (1991).
115. Paulsson, MA, et al. Thermal behavior of bovine lactoferrin in water and its relation to bacterial interaction and antibacterial activity. Journal of Dairy Science 76(12):3711-3720 (1993).
116. da Costa, RS, et al. Characterization of iron, copper and zinc levels in the colostrum of mothers of term and pre-term infants before and after pasteurization. International Journal of Food Science and Nutrition 54(2):111-117 (2003).
117. Holloway, NM, et al. Serum immunoglobulin G concentrations in calves fed fresh and frozen colostrum. Journal of the American Veterinary Medicine Association 219(3):357-359 (2001).